Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Charles Harrell, Ph.D.
Associate Principal scientist
Merck & Co., Inc.
Poster(s):
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Monday, October 21, 2024
2:30 PM – 3:30 PM
MT